1.07
Elutia Inc (ELUT) 最新ニュース
Elutia (ELUT) Expected to Announce Earnings on Wednesday - MarketBeat
Elutia regains compliance with Nasdaq listing requirements - Investing.com
Elutia regains Nasdaq compliance after meeting minimum bid price and MVLS - TradingView
Elutia Regains Full Nasdaq Compliance, Strengthening Listing Status - TipRanks
Elutia Regains Compliance with Nasdaq Listing Requirements - Bitget
Elutia (NASDAQ: ELUT) regains full Nasdaq listing compliance after bid price, value breach - Stock Titan
Elutia keeps its Nasdaq spot after meeting price, value rules - Stock Titan
Elutia names Pete Ligotti chief commercial officer - Investing.com
Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market - Bitget
New Elutia CCO targets 15–20% infection rates in breast reconstruction - Stock Titan
ELUT Should I Buy - Intellectia AI
Elutia to Report Fourth Quarter 2025 Financial Results on Wednesday, March 11, 2026 - Bitget
ELUT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Interview with the President and CEO: Elutia Inc. (NASDAQ:ELUT) - The Wall Street Transcript
Short Squeeze: What is the PEG ratio of Brookdale Senior Living IncStock Surge & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Where Purpose Meets Performance: Elutia Earns 2026 Great Place to Work Certification - HRTech Series
Where Purpose Meets Performance: Elutia Earns 2026 Great Place to Work Certification™ - The Manila Times
Risks Report: Is Elutia Inc subject to activist investor interest2025 Technical Overview & Expert Approved Momentum Ideas - baoquankhu1.vn
Targets Report: What is the Moat Score of Elutia IncJuly 2025 Earnings & Technical Confirmation Trade Alerts - baoquankhu1.vn
Alyeska discloses 3.18% Elutia (ELUT) stake in amended 13G - Stock Titan
Elutia Inc. (NASDAQ:ELUT) Surges 28% Yet Its Low P/S Is No Reason For Excitement - simplywall.st
Short Covering: Is Elutia Inc benefiting from innovation trendsJuly 2025 Big Picture & Community Verified Trade Signals - baoquankhu1.vn
What is Elutia Inc. s debt to equity ratioJuly 2025 Closing Moves & Safe Capital Growth Plans - mfd.ru
Nantahala reports 9.99% Elutia (ELUT) ownership stake in 13G/A - Stock Titan
CEO Moves: Is Elutia Inc benefiting from innovation trendsInsider Selling & Real-Time Volume Spike Alerts - baoquankhu1.vn
Will Elutia Inc. stock outperform value stocksGap Down & Technical Pattern Based Buy Signals - mfd.ru
Options Flow: Can Elutia Inc be recession proofPrice Action & Technical Confirmation Alerts - baoquankhu1.vn
Elutia Loses US$4.6m Market Value But Insiders See Windfall Of US$60k - simplywall.st
Insider Spends US$74k Buying More Shares In Elutia - Yahoo Finance
Aug Summary: What is the Moat Score of Elutia IncStop Loss & Smart Allocation Stock Tips - baoquankhu1.vn
Trend Report: Is Elutia Inc forming a breakout patternJuly 2025 Technicals & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
ELUTIA INC (ELUT) Upgraded to Buy: Here's What You Should Know - sharewise.com
Insider Buying: Guido Neels Acquires 20,000 Shares of Elutia Inc (ELUT) - GuruFocus
Elutia Inc. director Neels buys $20,800 in shares By Investing.com - Investing.com Australia
Elutia Inc. director Neels buys $20,800 in shares - Investing.com
Elutia launches $15M securities offering - MSN
Elutia Inc: director Neels buys $31.8k in company stock - Investing.com India
Elutia Inc: director Neels buys $31.8k in company stock By Investing.com - Investing.com South Africa
Insider Buying: Guido Neels Acquires 30,000 Shares of Elutia Inc (ELUT) - GuruFocus
Aug Movers: Can OPCH scale operations efficientlyMarket Performance Report & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Elutia sees Q4 net sales of $3.3M - MSN
Plus Therapeutics Spurs After-Hours Biotech Rally; Connect Biopharma And Elutia Also Advance - Nasdaq
Elutia reports 16% revenue growth, advances breast reconstruction product By Investing.com - Investing.com Canada
Elutia reports 16% revenue growth, advances breast reconstruction product - Investing.com
Elutia (ELUT) Strengthens Position with Drug-Eluting Platform - GuruFocus
Elutia reports preliminary fourth quarter 2025 results, strengthened financial position, and upcoming Nxt-41X milestones - marketscreener.com
大文字化:
|
ボリューム (24 時間):